The 20 Best Lung Adenocarcinoma Doctors Near Me in Mesquite, TX

John Minna is an Oncologist practicing medicine in Dallas, Texas. Dr. Minna is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).

Takashi Eguchi is a Thoracic Surgeon practicing medicine in Dallas, Texas. Dr. Eguchi is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, Pneumomediastinum, Thymectomy, and Endoscopy.

Sudha Teerdhala is an Oncologist and an Internal Medicine provider practicing medicine in Mesquite, Texas. Dr. Teerdhala is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Teerdhala is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

Samir Sejpal is a Radiation Oncologist practicing medicine in Mesquite, Texas. Dr. Sejpal is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Trigeminal Neuralgia, and Neuralgia. Dr. Sejpal is board certified in Radiation Oncology- American Board Of Radiology/Radiation Oncology and Radiation Oncology- American Board Of Radiology.

Adeel Shibli is a Pulmonary Medicine provider practicing medicine in Mesquite, Texas. Dr. Shibli is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, Hospital-Acquired Pneumonia, Pneumonia, and Gastrostomy.

Dr. Konduri attended medical school at the University College of Medical Sciences-India. He then completed a residency in Internal Medicine at Rush Presbyterian St Luke's - Westlake Residency Program, Melrose Park, Illinois, followed by a fellowship in Medical Oncology at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Konduri is certified in Internal Medicine and in Medical Oncology by the American Board of Internal Medicine. He specializes in medical oncology with a particular interest in lung and thoracic oncology. Dr. Konduri is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. Dr. Konduri is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Zhiyong Li is a Hematologist and an Oncologist practicing medicine in Garland, Texas. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma. Dr. Li is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology.

. Dr. Soriano is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Lung Metastases, and Gastrostomy. Dr. Soriano is board certified in American Board Of Internal Medicine.

Inderpal Sarkaria is a General Surgeon and a Thoracic Surgeon practicing medicine in Dallas, Texas. He has been practicing medicine for over 17 years. Dr. Sarkaria is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Esophageal Cancer, Lung Cancer, Thymectomy, and Endoscopy.

Alexandre Carvalho is a Pulmonary Medicine provider practicing medicine in Sunnyvale, Texas. Dr. Carvalho is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, and Bullae.

Mustafa Awili is an Intensive Care Medicine provider practicing medicine in Mesquite, Texas. Dr. Awili is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Hospital-Acquired Pneumonia, Atypical Pneumonia, Pneumonia, and Chronic Obstructive Pulmonary Disease (COPD).

Victor Horadam is a Hematologist practicing medicine in Mesquite, Texas. Dr. Horadam is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Malabsorption, and Myelodysplastic Syndrome (MDS).

Dr. Kummerfeldt specializes in pulmonary and critical care medicine. He is experienced the treatment of general pulmonary conditions such as pleural effusions, asthma, COPD, pulmonary nodules, cough and interstitial lung disease. He has a professional interest in pleural disease, thoracic and critical care ultrasound. Dr. Kummerfeldt is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, Advanced Bronchoscopy, and Gastrostomy. Dr. Kummerfeldt is board certified in Pulmonary Disease- American Board Of Internal Med/Pulmonary Disease, Critical Care Medicine- American Board Of Internal Med/Critical Care Medicine, Internal Medicine- American Board Of Internal Med, Neurocritical Care- American Board Of Internal Med/Neurocritical Care, Internal Medicine- American Board Of Internal Medicine, Pulmonary Disease- American Board Of Internal Medicine, Neurocritical Care- American Board Of Internal Medicine, and Critical Care Medicine- American Board Of Internal Medicine.

Dr. Schwartz is a thoracic surgeon with expertise in thoracic oncology, minimally invasive thoracic surgery, airway surgery, lung transplantation and extracorporeal membrane oxygenation. He completed a year of research focusing on thoracic oncology and endoscopic airway interventions. He has published many peer-reviewed publications and earned multiple clinical awards, including Chief Resident of the Year and the Charles McBurney Award. In addition, Dr. Schwartz serves in the following roles at Baylor University Medical Center: Chief, Department of Thoracic Surgery; Surgical Director, Lung Transplantation; Medical Director, Extracorporeal Membrane Oxygenation; and Surgical Director, Major Airway Disorders. He is married with four children and enjoys traveling, cooking, swimming and yoga. See Dr. Schwartz's Publications. Dr. Schwartz is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Lung Transplant, and Gastrostomy. Dr. Schwartz is board certified in General Surgery- American Board Of Surgery/General Surgery, Thoracic And Cardiac Surgery- American Board Of Thoracic Surgery/Thoracic And Cardiac Surgery, General Surgery- American Board Of Surgery, and Thoracic And Cardiac Surgery- American Board Of Thoracic Surgery.

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018. Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals. Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas. Publications. Dr. Kelly is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Kelly is board certified in Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Med/Medical Oncology, - American Board Of Internal Med, - American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Dr. Nadler specializes in medical oncology. He serves as a Medical Director of US Oncology Health Informatics and Internet Technology. He remains active in USON research committees in lung cancer, head and neck cancer, and sarcoma within the developmental committees. Dr. Nadler received a BA with highest honors from Wesleyan University double majoring in molecular biology and philosophy. He received his joint MD/MPP from Harvard Medical School and a Master in Public Policy from Harvard University's Kennedy School of Government. Dr. Nadler then completed his internship and residency in Boston, MA, at Brigham and Women's Hospital in Boston and his oncology fellowship at Dana Farber Cancer Institute/MGH. Dr. Nadler is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Adenoid Cystic Carcinoma, Bone Tumor, and Fibrosarcoma. Dr. Nadler is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

David Mason is a General Surgeon and a Thoracic Surgeon practicing medicine in Dallas, Texas. Dr. Mason is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, EGFR Positive Lung Cancer, Gastrostomy, and Endoscopy. Dr. Mason is board certified in Thoracic Surgery- American Board Of Thoracic Surgery/Thoracic And Cardiac Surgery, General Surgery- American Board Of Surgery/General Surgery, Thoracic And Cardiac Surgery- American Board Of Thoracic Surgery/Thoracic And Cardiac Surgery, General Surgery- American Board Of Surgery, and Thoracic And Cardiac Surgery- American Board Of Thoracic Surgery.

Dr. Kopita is board-certified in pulmonary medicine as well as hospice and palliative medicine. He attained his medical degree from the Medical College of Ohio in Toledo. He then completed his residency in internal medicine and a fellowship in pulmonary and critical care medicine at Duke University Medical Center in Durham, NC. Dr. Kopita’s clinical interests include palliative medicine, thoracic oncology, dyspnea, chronic cough, asthma, bronchiectasis, nontuberculous mycobacterial disease and chronic obstructive pulmonary disease (COPD) as well as bronchoscopy. Dr. Kopita is married with two children and enjoys listening to music, traveling and photography. He currently serves as medical director of Baylor Scott & White Pulmonary and Sleep Specialists. Dr. Kopita is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Bronchiectasis, Lung Metastases, Emphysema, and Bullae. Dr. Kopita is board certified in Hospice & Palliative Medicine- American Board Of Internal Med/Hospice And Palliative Medicine, Pulmonary Disease- American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease- American Board Of Internal Medicine, and Hospice And Palliative Medicine- American Board Of Internal Medicine.

Dr. Podgaetz has a professional goal to identify the best treatments for his patients - tailoring therapy by considering not only the disease, but also the personal situation of each patient and family. Dr. Podgaetz completed medical school at La Salle University School of Medicine in Mexico City. He moved to the United States to complete his internship in general surgery at Mayo Clinic in Rochester, Minnesota. From there he continued his training at Mayo Clinic and George Washing University in Washington D.C. It was there he found interest in thoracic oncology, treating pulmonary, esophageal and mediastinal tumors leading him to complete a fellowship in cardiothoracic surgery at Massachusetts General Hospital in Boston, MA. Dr. Podgaetz believes and promotes the benefits of minimally invasive thoracic surgery (VATS and Robotic) for his patients as this helps accelerate recovery, minimize pain and shorten hospital stay. One of his areas of interest is Enhanced Recovery After Surgery (ERAS) for thoracic surgery. This multimodal strategy synergistically helps patients recover faster and regain their full preoperative functional status sooner. He has been teaching since 2003 and is committed to surgical education, helping new generations of young surgeons learn and become proficient in thoracic surgery diseases. Dr. Podgaetz has authored multiple peer reviewed publications, articles, chapters, abstract and presentations at national and international meetings. He enjoys spending time with family, traveling, cycling and reading/audiobooks. See Dr. Podgaetz’s Publications. Dr. Podgaetz is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Achalasia, Esophageal Perforation, Pleuropulmonary Blastoma, Endoscopy, and Gastrostomy. Dr. Podgaetz is board certified in Thoracic And Cardiac Surgery- American Board Of Thoracic Surgery/Thoracic And Cardiac Surgery, General Surgery- American Board Of Surgery/General Surgery, General Surgery- American Board Of Surgery, and Thoracic And Cardiac Surgery- American Board Of Thoracic Surgery.

Dr. Kumar is a fellowship-trained and board-certified interventional pulmonologist with expertise in a wide range of minimally invasive pulmonary procedures. He has a particular focus on lung cancer diagnostic and procedural interventions, bronchoscopic lung volume reduction (BLVR) for COPD, ultrasound-guided pulmonary procedures, and both benign and malignant pleural diseases. In addition to his clinical practice, Dr. Kumar serves as the medical director of interventional pulmonology at Baylor University Medical Center, part of Baylor Scott & White Health. When his busy schedule allows, Dr. Kumar enjoys playing badminton, table tennis, pool, swimming, watching movies or sports, traveling, and spending quality time with his family and friends. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Lung Nodules, and Advanced Bronchoscopy. Dr. Kumar is board certified in Pulmonary Disease- American Board Of Internal Med/Pulmonary Disease, Critical Care Medicine- American Board Of Internal Med/Critical Care Medicine, - American Board Of Internal Med/Geriatric Medicine, Geriatric Medicine- American Board Of Internal Med/Geriatric Medicine, Pulmonary Disease- American Board Of Internal Medicine, Critical Care Medicine- American Board Of Internal Medicine, and Internal Medicine- American Board Of Internal Medicine.